MLA
VRTX icon

My Legacy Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

My Legacy Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$1.09M Buy
2,263
+63
+3% +$29K 0.39% 74
2025
Q1 		$1.07M Buy
2,200
+49
+2% +$22.8K 0.41% 70
2024
Q4 		$913K Sell
2,151
-76
-3% -$35.2K 0.35% 77
2024
Q3 		$1.04M Sell
2,227
-379
-15% -$182K 0.41% 70
2024
Q2 		$1.22M Buy
2,606
+282
+12% +$122K 0.39% 64
2024
Q1 		$971K Buy
2,324
+507
+28% +$214K 0.33% 85
2023
Q4 		$781K Buy
1,817
+592
+48% +$219K 0.28% 105
2023
Q3 		$447K Buy
1,225
+80
+7% +$28K 0.18% 149
2023
Q2 		$400K Buy
1,145
+72
+7% +$24.3K 0.16% 164
2023
Q1 		$347K Buy
1,073
+396
+58% +$119K 0.15% 171
2022
Q4 		$204K Buy
+677
New +$206K 0.09% 203

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

My Legacy Advisors's VRTX Position: Q2 2025 in Review

My Legacy Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 2.9% in Q2 2025, buying an estimated $29K and bringing the position to 2,263 shares worth $1.09M. The position accounts for 0.39% of the portfolio, ranked #74.

My Legacy Advisors first reported a position in VRTX in Q4 2022 and has held it in 11 quarters since. The position peaked at $1.22M in Q2 2024. 1,559 funds tracked by Wall St. Rank hold VRTX as of Q2 2025.

  • My Legacy Advisors held 2,263 shares of Vertex Pharmaceuticals worth $1.09M as of Q2 2025.
  • My Legacy Advisors bought 63 Vertex Pharmaceuticals shares in Q2 2025, an estimated $29K.
  • Vertex Pharmaceuticals made up 0.39% of My Legacy Advisors's portfolio in Q2 2025, its #74 holding.
  • My Legacy Advisors first reported a position in Vertex Pharmaceuticals in Q4 2022 and has held it in 11 quarters since.
  • My Legacy Advisors's Vertex Pharmaceuticals position peaked at $1.22M in Q2 2024.
  • 1,559 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2025.

Based on My Legacy Advisors's 13F filing for Q2 2025, filed 11 Jul 2025.